Insulin resistance links nonalcoholic fatty liver to cardiovascular diseases

Hepatology

Volumn 53, Issue 5, 2011, Pages 1785-1786

  Salamone, Federico ^a   Galvano, Fabio ^a   Li Volti, Giovanni ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VERY LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE COURSE; GLUCOSE HOMEOSTASIS; GROUPS BY AGE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LETTER; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL;

CARDIOVASCULAR DISEASES; FATTY LIVER; HUMANS; INSULIN RESISTANCE;

EID: 79955119010     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24115     Document Type: Letter

References (4)

1. Ghouri N, Preiss D, Sattar N. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. HEPATOLOGY 2011; 52: 1156-1161.
2. Perseghin G. Viewpoints on the way to a consensus session: where does insulin resistance start? The liver. Diabetes Care 2009; 32(Suppl 2): S164-S167.
3. Han S, Liang CP, Westerterp M, Senokuchi T, Welch CL, Wang Q, et al. Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice. J Clin Invest 2009; 119: 1029-1041.
4. Perseghin G, Lattuada G, De Cobelli F, Esposito A, Belloni E, Natali G, et al. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver. HEPATOLOGY 2008; 47: 51-58.